Company ProfilePremium

Aries Agro Limited

Company Profile Analysis

Tickers: ARIES.NS, 532935.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Aries Agro Limited - Company showcase

Year Founded & Workforce

1969

Aries Agro Limited logo

Aries Agro Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Aries Agro Limited Overview

Aries Agro is one of India's longest-established specialty plant-nutrition companies and a pioneer of chelated micronutrient fertilisers in the country, having introduced the Agromin chelated micronutrient mixture in 1975 and Chelamin chelated zinc in 1976. It is a promoter-controlled micro-cap (Mirchandani family 52.66%) whose business is almost entirely domestic, dealer-distributed, highly seasonal, and working-capital intensive. Its product basket spans chelated and non-chelated micronutrients, secondary nutrients (sulphur, calcium, magnesium), water-soluble and specialty fertilisers, bio-stimulant-type plant-health products, and a small but fast-growing farm-equipment/pest-trap line. CRISIL (January 2022) estimated the group's share of the organised domestic chelated-micronutrient market at roughly 30%, making it the category leader. After a decade of stagnant returns, FY2025–FY2026 marked an inflection: consolidated revenue grew ~19–20% per year, PAT more than doubled over two years, net debt fell to near zero, and the working-capital cycle compressed sharply — catalysing a re-rating of the stock.


What the company does

Aries Agro manufactures, imports, formulates and markets micronutrients and other customised nutritional products, principally for plants and historically also for animals (the company's origin was mineral feed additives for livestock and poultry). Today, the plant-nutrition business dominates: the company reports a single operating segment labelled "Micronutrient Fertilizers" in its exchange filings (iXBRL, Q2 FY2026).

The product range covers:

Micronutrients: zinc, iron, manganese, copper, boron, molybdenum, in chelated (EDTA-type metal chelates) and non-chelated forms, both single-element and multi-nutrient mixtures (flagships Agromin and Chelamin).

Secondary nutrients: sulphur, magnesium and calcium (added 2001), including sulphur bentonite and sulphur-based pastillated products manufactured in the UAE.

Specialty and water-soluble nutrition: crop-specific formulations (e.g., Majorsol Soybean & Pulses Special), concentrated liquid micronutrients (Zinc HD Gold, Agromin Max HD), calcium–magnesium sources (Calmax), silicon (Aries Silica).

Plant-health / immunity / bio-inputs: Aries Ecoshield (plant immunity booster), bio-fertilisers (entered with the Ahmedabad unit in 2008).

Agri-equipment and IPM devices: via subsidiary Aries Agro Equipments Pvt Ltd (e.g., Magic Traps, Aries Trap X, Aries Suraksha) and soil-management technology (Aries Soil Wrap).

The company also maintains exclusive marketing arrangements with overseas plant-nutrition manufacturers (Europe, Turkey, Singapore, USA, South America), adapting imported products to Indian conditions — a "Made for India" positioning it has long used (company profile).

Business and revenue model

DimensionCharacterisation
Revenue modelAlmost entirely product sales (manufactured and traded fertiliser products). No meaningful service, subscription or licensing revenue disclosed.
ChannelBusiness-to-business-to-farmer: sales to dealers/distributors who extend credit to retailers and farmers. FY2026 annual booking involved 1,717 dealers across 26 states (Board's Report FY2025).
Demand-booking mechanismAn annual "booking bazaar" / online booking app where dealers place forward bookings for the year: INR 835.10 cr booked for FY2025 and INR 830.44 cr for FY2026 (MD&A FY2025; Board's Report FY2025).
Gross-to-netSignificant trade discounts/rebates: consolidated FY2025 gross revenue INR 804.59 cr vs. net revenue INR 622.22 cr (discounts ~INR 182 cr, ~22.6% of gross). FY2026 gross INR 956.88 cr vs. net INR 740.06 cr.
SeasonalityStrong concentration in Q2 (kharif) and Q3 (rabi); Q4 is structurally weak and frequently loss-making (Q4 FY2026 consolidated loss of INR 4.79 cr). Management explicitly flags cropping patterns, seasonality and weather as drivers (Q1 FY2027 press release).
Value-chain positionMid-stream formulator/manufacturer: imports or buys metal salts, chelating agents, sulphur, etc.; formulates, packages and brands; relies heavily on field-extension marketing (3,958 farmer meetings reaching 54,948 farmers in FY2026).
CustomersDealers/distributors (direct customers); end users are farmers — field crops (cereals, pulses, oilseeds, sugarcane) and high-value horticulture (grapes, potatoes, mangoes, vegetables). Institutional/government sales: not separately disclosed.
End-marketsIndian agriculture overwhelmingly; limited exports/overseas sales via the UAE subsidiary (Golden Harvest Middle East FZC) and associate (Amarak Chemicals FZC).

Company's own description vs. independent characterisation

Company's description (paraphrased from FY2026 press release and FY2025 Annual Report): Aries describes itself as one of India's leading plant-nutrition and specialty agri-input companies with a 57-year legacy, deep farmer connections, a diversified product portfolio and an innovation-led approach, aiming to become a globally competitive agri-nutrition enterprise.

Independent characterisation: Aries is a niche, promoter-run, India-centric specialty fertiliser formulator that is unsubsidised (micronutrients sit outside India's Nutrient Based Subsidy regime for primary fertilisers), brand- and extension-driven, and historically constrained by a very long cash-conversion cycle and thin net margins (3–4%). The FY2025–FY2026 improvement appears driven by operating leverage, lower interest costs from deleveraging, and much tighter receivables management rather than by a structural change in the business model. It remains small (FY2026 net revenue ~INR 740 cr, ~USD 85–90 m) relative to diversified fertiliser majors that also sell micronutrients.

Strategy

Stated strategic themes (paraphrased from FY2026 press release, FY2025 Annual Report and October 2026 company-sourced coverage)

  1. Innovation-led specialty nutrition — continued launches of concentrated (HD), crop-specific and plant-health products (FY2025: Ecoshield, Majorsol, Calmax, Zinc HD Gold; FY2026: Trillion, Silica, Agromin Max HD).

  2. Farmer-centric extension marketing — meetings, Kisan Melas and partnerships with grower associations (Punjab potato, Maharashtra mango, Karnataka GKVK).

  3. Operational and working-capital discipline — explicit targets/achievements on inventory days (60 → 55) and receivable days (53 → 35), working-capital cycle 89 → 64 days.

  4. Manufacturing expansion and modernisation — capacity to 101,400 MT p.a., automation at Vijayawada and Nashik, owned-premises relocation in UP.

  5. Distribution deepening — depot network expanded to 30.

  6. Digitalisation — booking app, AIMS ERP, Aries Everywhere field monitoring, digitised Magic Traps; MoU with Jio (c. 2024).

  7. Brand building — Sourav Ganguly as brand ambassador (3 years from Mar 2026); mascot "Jeevan".

  8. Long-term aspiration — to become a globally competitive, sustainable agri-nutrition enterprise.

Initiative register (last 24 months)

DateInitiativeTypeDetail
FY2025New products (Ecoshield, Majorsol Soybean & Pulses Special, Calmax, Zinc HD Gold)ProductMD&A FY2025
FY2025Groundbreaking of new Lucknow-area facility; Vijayawada office expansionFootprintIIFL summary
Sep 2024–Feb 2025Farmer events (Kartarpur, GKVK Bangalore, Vishaka Organic Mela, Mumbai mango growers) and IMMA B2B conclave at BSE (8 Feb 2025)Marketing / partnershipsMD&A FY2025
Aug 2025 (for FY2026)Online annual booking: INR 830.44 cr from 1,717 dealers; company aimed for ~INR 950 cr in FY2026CommercialBoard's Report FY2025
12 Feb 2026Sayakha plant (+6,000 MT p.a.)CapacityReg. 30
5 Mar 2026Unnao relocated plant (~INR 12 cr, internal accruals)FootprintReg. 30
30 Mar 2026Sourav Ganguly brand ambassadorBrandExchange disclosure
FY202630 depots; automation at Vijayawada and Nashik; launch of Trillion, Silica, Agromin Max HD, Suraksha, Trap X, Soil WrapDistribution / productGlobal Agriculture, Oct 2026
May 2026Special dividend INR 1 per shareCapital allocationBoard, 28 May 2026

Medium-term guidance / targets

Management does not publish formal financial guidance. The only quantitative forward indicators found are the annual dealer booking (INR 830.44 cr for FY2026) and an implied FY2026 revenue aspiration of ~INR 950 cr (Board's Report FY2025), against which actual standalone gross revenue was INR 917.64 cr and consolidated gross INR 956.88 cr. ESG or cost-programme targets: not publicly disclosed.

Products & Services

Aries does not publish revenue by product. The catalog below lists all products and brands identified in filings, chairman's speeches, MD&A and company-sourced media; launch years given where disclosed. Pricing models are not disclosed (products are sold at dealer price lists with trade discounts).

Micronutrients (core)

Brand / productDescriptionTarget customer / cropLaunchSource
AgrominChelated multi-micronutrient fertiliser; India's first chelated micronutrient productBroad-acre and horticulture farmers1,975Company profile
ChelaminChelated zincZinc-deficient soils (rice, wheat, maize)1,976Company profile
Agromin Max HDHigh-density / concentrated variant of AgrominFarmers seeking lower application volumesFY2026Global Agriculture, Oct 2026
Zinc HD GoldConcentrated liquid zincFoliar applicationFY2025MD&A FY2025
GrapeminCrop-specific micronutrient mix for grapesGrape growers (Maharashtra)c. 2024 (n.v.)ROIC.ai summary
High-density fertiliser rangeNew "HD" concentrated formulations—c. 2024ROIC.ai summary
Soluble boronWater-soluble boronOilseeds, fruits, vegetablesManufactured in UAE from 2011Company history

Secondary nutrients

ProductDescriptionLaunchSource
Sulphur, magnesium, calcium rangeSecondary nutrient fertilisers2,001Company profile
Sulphur bentoniteSlow-release elemental sulphurUAE production 2011Company history
Sulphur-based pastillated products (four products)Value-added sulphur pastilles for India and exportFujairah restart Sep 2021Chairman's speech 2022
CalmaxPlant-based source of calcium and magnesiumFY2025MD&A FY2025

Specialty, crop-specific and biostimulant-type products

ProductDescriptionLaunchSource
Majorsol Soybean & Pulses SpecialCrop-specific specialty nutrition for growth and seed setFY2025MD&A FY2025
Aries EcoshieldPlant immunity boosterFY2025MD&A FY2025
Aries TrillionNew plant-nutrition product (specification n.d.)FY2026Global Agriculture, Oct 2026
Aries SilicaSilicon-based crop inputFY2026Global Agriculture, Oct 2026
Bio-fertilisers rangeBiological fertilisers2008 (Ahmedabad unit)Company history
Organic farming solutionsShowcased at organic melas2,024MD&A FY2025

Agri-equipment, IPM and soil technology (Aries Agro Equipments Pvt Ltd)

ProductDescriptionLaunchSource
Magic TrapsPest traps; digitisation programme highlightedPre-FY2025MD&A FY2025
Aries Trap XPest trapFY2026Global Agriculture, Oct 2026
Aries SurakshaAgricultural equipment / protective product (spec. n.d.)FY2026Global Agriculture, Oct 2026
Aries Soil WrapSoil-management (mulch-type) technologyFY2026Global Agriculture, Oct 2026
Imported farm equipmentTrading of farm equipmentOngoingCRISIL rationale

Animal nutrition (legacy)

Mineral premixes, milk boosters, protein concentrates, vitamin premixes and feed additives formed the company's original business. Current revenue contribution is not publicly disclosed; the reported single segment is "Micronutrient Fertilizers".

Digital and farmer-engagement platforms (non-revenue)

PlatformFunctionSource
Aries booking appOnline annual dealer booking (1,717 dealers, 26 states for FY2026)Board's Report FY2025
AIMS – Aries Integrated Management SystemInternal ERP/management platformMD&A FY2025
Aries EverywhereSales and field-activity monitoringMD&A FY2025
Kisan Melas / farmer meetings3,958 meetings, 54,948 farmers reached in FY2026Global Agriculture, Oct 2026

Financial Narrative

All figures consolidated, INR cr, fiscal years ending 31 March. Primary sources: audited results filings (FY2025, FY2026), FY2026 press release; supplemented by StockAnalysis, TipRanks, Anand Rathi and Tapetide for earlier years. EBITDA is the company's/aggregator "operating profit" definition (matches the company's FY2025–FY2026 press-release EBITDA).

Income statement

Notes: (1) EPS is on profit attributable to owners (e.g., FY2025 INR 34.0 cr; FY2026 INR 42.85 cr). (2) FY2026 DPS: a special dividend of INR 1.00 is confirmed (board, 28 May 2026); the total of INR 2.50 (implying a final of INR 1.50) is from an aggregator (DivvyDiary) and should be confirmed against the AGM notice. (3) Dividend shown against the fiscal year to which it relates. (4) Minor discrepancies: Screener shows FY2025 PBT INR 44 cr and interest INR 19 cr; TipRanks shows FY2025 EBITDA INR 72.3 cr (consistent).

Margin profile

Revenue CAGR FY2022–FY2026: ~14.4% (net revenue, consolidated). PAT CAGR FY2022–FY2026: ~34.5%.

Commentary. The P&L shows two distinct regimes. FY2022–FY2024 was a low-growth, high-interest period: revenue compounded ~9%, gross margins fell sharply in FY2023 (raw-material inflation and supply-chain volatility), and finance costs absorbed ~40% of EBIT, keeping net margins near 3–3.6%. FY2025–FY2026 is the inflection: revenue accelerated to ~19–20% p.a., interest cost fell ~19% in FY2025 as debt was repaid, and PBT margin widened ~260 bp over two years. Importantly, gross margin has declined (43.0% → 40.4%) over FY2024–FY2026, implying growth has come with a richer share of lower-margin or traded products, heavier discounts, or input-cost pass-through lags; the EBITDA margin has been held only through operating leverage on selling and administrative costs. Below-the-line, FY2026 benefited from INR 12.7 cr of other non-operating income (StockAnalysis), which contributed to the 36% PBT growth — a quality-of-earnings point to monitor.

Quarterly profile (consolidated, INR cr)

Q2 FY2026 revenue derived as FY2026 total less the other three quarters. Q1 FY2027: owners' share of PAT INR 14.91 cr (+48.7% YoY); standalone net revenue INR 180.83 cr (+17.3%). PTI reported "total revenue" of INR 237.05 cr — this appears to be a gross figure before discounts; the company's net figure is INR 185.86 cr. Aggregator figures of INR 185–188 cr differ marginally due to rounding/other income.

Balance sheet (consolidated, INR cr, 31 March)

Notes: Balance-sheet line items from StockAnalysis (INR million converted); total borrowings derived as net debt + cash and corroborated by Tapetide (112/100/74/49/56). Goodwill: none disclosed. Book value per share: Bajaj Broking publishes two series without labelling standalone vs consolidated; both are shown. Derived equity on Basis A: ~INR 211 cr (FY2022) rising to ~INR 290 cr (FY2026).

Commentary. The balance sheet has de-risked materially. Net debt fell from INR 112 cr (FY2022) to INR 7 cr (FY2026), and the company now holds ~INR 49 cr of cash and short-term investments. The FY2026 decline in receivables (INR 118 cr → INR 93 cr) despite ~19% revenue growth is the single most notable balance-sheet development and supports the company's claim that receivable days fell from 53 to 35. PP&E has more than doubled since FY2022 (Hyderabad Phase 3, Raipur, Chhatral, Sayakha, Unnao), indicating the company is in an investment phase financed largely from internal accruals. Long-term investments (~INR 65 cr) likely include the UAE associate and other strategic holdings; their recoverability is a diligence point.

Cash flow (consolidated, INR cr)

Sources: Tapetide (FCF series); share.market (FY2026 cash-flow statement).

Commentary. Aries has generated positive FCF in every year shown, averaging ~INR 52 cr p.a. — high relative to reported PAT, reflecting non-cash charges and working-capital release. FY2026 FCF fell to ~INR 38 cr because capex stepped up to ~INR 48 cr (Sayakha, Unnao relocation, automation at Vijayawada and Nashik) and the company parked ~INR 19 cr in short-term investments (investing outflow of INR 77.7 cr includes treasury placements).

Ratios

Notes: ROE and D/E use Basis A equity (see 6.4) and are approximations. Screener reports a 3-year average ROE of 9.25% (through FY2025), consistent with the approximations above.

Overall financial verdict. The company has moved from a leveraged, low-return, working-capital-trapped business (ROE ~6–8%) to a near-debt-free business earning mid-teens ROE. Sustainability depends on (a) holding receivable discipline through a weak monsoon year, (b) arresting gross-margin erosion, and (c) earning a return on the expanded fixed-asset base at ~72% capacity utilisation.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment

SegmentFY2024FY2025FY2026

Micronutrient Fertilizers revenue (INR Cr)

516.46622.22740.06

Micronutrient Fertilizers PBT (INR Cr)

28.3844.3960.29

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment Margins & Growth (%) and Revenue by Segment (%)

Segment metricFY2024FY2025FY2026

YoY revenue growth (%)

9.420.518.9

PBT margin on net revenue (%)

5.57.18.1

Share of total revenue (%)

100100100

Revenue by Segment — Gross revenue from operations

MetricFY2024FY2025FY2026

Gross revenue from operations (INR Cr)

672.86804.59956.88

Discounts and rebates (INR Cr)

156.40182.18216.82

Net revenue from operations (INR Cr)

516.46622.22740.06

Group Entities

EntityRelationshipCountryActivityNotes

Mirabelle Agro Manufacturing Pvt Ltd

Wholly owned subsidiary

India (Chhatral, Gujarat)

Manufacturing

Incorporated 26 Dec 2019; FY2026 revenue growth 48.98%

Aries Agro Equipments Pvt Ltd

Wholly owned subsidiary

India

Import and trading of farm equipment, traps

FY2026 revenue growth 91.81%

Golden Harvest Middle East FZC

Subsidiary (75% acquired 2008; current stake n.v.)

UAE (Sharjah/Fujairah)

Manufacturing of chelates, soluble boron, sulphur products

Likely the non-wholly-owned subsidiary given non-controlling-interest losses (inference)

Amarak Chemicals FZC

Associate (49% via Golden Harvest)

UAE

Chemicals manufacturing

Reportedly commenced operations at a facility in Feb 2026 (details n.v.)

Aries Agro Care Pvt Ltd

Former subsidiary (seeds trading)

India

—

Listed in CRISIL 2024 rationale; current status n.v.

Aries Agro Produce Pvt Ltd

Former subsidiary

India

—

Appeared in older annual reports; current status n.v.

Segment Revenue

MetricStandaloneConsolidated

Net revenue from operations

701.83740.06

Gross revenue

917.64956.88

PBT

53.4560.29

PAT

38.3742.37

Q4 FY2026 PAT

-3.48-4.79

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Net revenue from operations (INR Cr)

432.4472.2516.5622.2740.1

Total income incl. other income (INR Cr)

443.9481.1519.4627.1752.8

Gross profit (INR Cr)

200.9192.9222.3259.1298.9

EBITDA (INR Cr)

50.556.658.472.388.9

Operating income / EBIT (INR Cr)

41.039.947.757.865.3

Interest expense (INR Cr)

23.321.721.317.417.7

Profit before tax (INR Cr)

20.325.428.444.460.3

Net income / PAT (INR Cr)

12.915.918.433.542.4

EPS basic and diluted (INR)

10.2213.1714.9426.1632.95

Dividend per share (INR)

0.801.001.001.202.50

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin (%)

46.540.943.041.640.4

EBITDA margin on net revenue (%)

11.712.011.311.612.0

Operating (EBIT) margin (%)

9.58.59.29.38.8

PBT margin (%)

4.75.45.57.18.1

Net margin (%)

3.03.43.65.45.7

Revenue growth YoY (%)

13.39.29.420.518.9

Revenue History

QuarterNet revenuePBTPAT

Q1 FY2026 (Jun 2025)

159.79

n.v.

9.93

Q2 FY2026 (Sep 2025)

200.11 (derived)

28.0519.92

Q3 FY2026 (Dec 2025)

200.9423.8417.31

Q4 FY2026 (Mar 2026)

179.22-6.10-4.79

FY2026 total

740.0660.2942.37

Q1 FY2027 (Jun 2026)

185.8619.6214.85

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

509.0519.8517.5581.4638.8

Cash and short-term investments (INR Cr)

0.71.92.430.748.7

Total borrowings (INR Cr)

112.399.773.648.655.7

Net debt (INR Cr)

111.697.871.117.97.1

Trade receivables (INR Cr)

118.6118.4113.4117.992.8

Inventory (INR Cr)

147.1143.9126.4132.8143.9

Property, plant and equipment (INR Cr)

67.675.097.6119.4156.2

Long-term investments (INR Cr)

57.562.363.264.864.8

Intangible assets (INR Cr)

0.130.120.110.110.39

Book value per share, Basis A (INR)

161.92172.44186.75200.20222.68

Book value per share, Basis B (INR)

146.51160.45174.91190.54211.09

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Free cash flow (INR Cr)

6339467438

Metric (FY2026 only, INR Cr)

Value

————

Operating cash flow

86.08————

Investing cash flow

-77.72————

Financing cash flow

-12.18————

Net change in cash

-3.82————

Implied capex (OCF − FCF)

~48

————

Dividends paid (FY2025 dividend of INR 1.20 × 13.0 m shares)

~1.6

————

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE on average equity, Basis A (%)

6.37.37.913.315.4

ROA (PAT / year-end total assets, %)

2.53.13.65.86.6

Debt to equity, Basis A (x)

0.530.440.300.190.19

Net debt to EBITDA (x)

2.211.731.220.250.08

Interest coverage, EBITDA / interest (x)

2.172.602.744.165.01

Asset turnover (x)

0.850.911.001.071.16

Cash conversion cycle, aggregator (days)

224212191159115

Region Overview

RegionEvidenceRevenue share

India

Dealer base of 1,717 dealers across 26 states; 30 depots; nine Indian manufacturing/packing sites

Not disclosed; estimated to be the substantial majority

UAE / Middle East / export

Golden Harvest Middle East and associate Amarak Chemicals manufacture sulphur and chelated products "for sale in India and globally"

—

“—” = not publicly disclosed.

Geographic Revenue

RegionFY2024FY2025FY2026

Total (all geographies, consolidated)

516.46622.22740.06

Standalone (India parent)

507.65597.65701.83

Valuation Snapshot

MetricValueDateSource

Last price (NSE)

INR 479.90

14 Oct 2026

IIFL

Market cap

~INR 624 cr

14 Oct 2026

IIFL

52-week range

INR 285.35 – 524.75

14 Oct 2026

IIFL

P/E (TTM)

14.6x

14 Oct 2026

IIFL

P/B

2.0x

14 Oct 2026

IIFL

1-year return

~+17.6%

to 17 Sep 2026

Anand Rathi

6-month return

~+46.7%

to 17 Sep 2026

Anand Rathi

3-year return

~+172%

to 17 Sep 2026

Anand Rathi

5-year return

~+155%

to 20 Mar 2026

Univest

Valuation Multiples

MultipleAries AgroBasis

P/E (FY2026 EPS INR 32.95)

14.6x

Price / EPS

EV (market cap + net debt INR 7 cr)

~INR 631 cr

—

EV/EBITDA (FY2026 EBITDA INR 88.9 cr)

~7.1x

—

EV/Sales (FY2026 net revenue INR 740 cr)

~0.85x

—

P/B

~2.0–2.2x

Depends on book-value basis

Dividend yield (FY2026 total INR 2.50, if confirmed)

~0.5%

—

Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025FY2026

Dividend per share (INR)

0.800.801.001.001.202.50

Dividend as % of face value

8810101225

Credit Ratings

AgencyRatingOutlookDateFacilities

CRISIL Ratings

BBB+ (LT) / A2 (ST)

Positive

27 May 2024 (reaffirmed Aug 2025 per Board's Report; current outlook n.v.)

INR 150 cr bank facilities

CRISIL Ratings

BBB+ / A2

Stable

30 Mar 2023

INR 150 cr

CRISIL Ratings

BBB+ / A2 (assigned)

Stable

11 Jan 2022

INR 150 cr

Brickwork Ratings

BWR BBB / A3+

Stable

8 Feb 2021

INR 163.36 cr

CARE Ratings

BBB- / A3 (reaffirmed and withdrawn)

Stable

3 Dec 2020

INR 175.05 cr

Moody's / S&P / Fitch

Not rated

———

Analyst Conclusions

Management guidance

No quantitative guidance is issued. Qualitatively, management (FY2026 and Q1 FY2027 press releases) expects to strengthen its growth trajectory on the back of distribution expansion, a diversified portfolio and research-driven solutions, while cautioning that results are inherently affected by seasonality, cropping patterns and weather.

Consensus expectations

No institutional consensus exists. For framing only: if FY2027 revenue grows in line with Q1 (+16%) to ~INR 860 cr at a stable ~5.7% net margin, PAT would be ~INR 49 cr (EPS ~INR 38), implying ~12.6x FY2027E P/E at the current price. This is an illustrative sensitivity, not a forecast.

Bull case

  1. Structural re-rating of a de-risked business — net debt/EBITDA has fallen from 2.2x to 0.08x and ROE from ~6% to ~15%; at ~7x EV/EBITDA the stock still discounts the old, leveraged business.

  2. Operating leverage on installed capacity — 28% unused capacity after the Sayakha addition allows growth without major capex, lifting FCF back toward the FY2025 level (~INR 74 cr).

  3. Mix upgrade and adjacencies — HD/liquid formulations, crop-specific products and the fast-growing equipment subsidiary (+92%) can stabilise gross margin while broadening the addressable market.

Bear case

  1. Gross-margin erosion is real — down ~260 bp over two years; if it continues while selling costs rise (brand ambassador, depots), operating leverage reverses.

  2. Working-capital gains may be cyclical — receivable days fell sharply in a good agricultural year; a poor monsoon could reverse collections, as the company's 400–600-day CCC history shows.

  3. Earnings quality and disclosure — FY2026 PBT growth benefited from ~INR 12.7 cr of other non-operating income; there are no earnings calls, segment detail or R&D disclosure, limiting institutional conviction and liquidity.

Catalysts and monitorables (next 12 months)

ItemExpected timingWhat to watch
Q2 FY2027 results~mid-Nov 2026Kharif-season revenue growth vs Q2 FY2026 (INR 200 cr); gross margin; receivables
Q3 FY2027 results~mid-Feb 2027Rabi demand; PAT run-rate
FY2027 annual booking disclosureIn FY2026 Annual Report / 2026 AGM materialsGrowth over INR 830 cr
Monsoon 2027 forecast (IMD)Apr–May 2027Sets FY2028 demand tone
FY2027 results and dividendMay 2027Sustained payout increase; special dividend repeat
Credit-rating review (CRISIL)~Aug 2027Possible upgrade to A- given deleveraging
Transmission of late director's ~20% stakeAny timePromoter structure clarity
Amarak / UAE operationsOngoingTurnaround or impairment of ~INR 65 cr investments
Capacity utilisationOngoingMovement above 72%
Institutional entry (MF/DII)OngoingShareholding filings

Concluding analyst verdict

Aries Agro has spent most of its listed life as a classic "good franchise, poor economics" micro-cap: a genuine category pioneer in Indian chelated micronutrients whose returns were consumed by a bloated working-capital cycle, heavy trade discounting and interest costs. The evidence from FY2025 and FY2026 indicates a real, not cosmetic, change. Net debt has been almost eliminated, interest coverage has more than doubled to ~5x, receivable days have fallen to ~35, and ROE has roughly doubled to the mid-teens — all while revenue compounded at ~19–20% per year and capacity was expanded largely from internal cash. The Q1 FY2027 print (+16% revenue, +49% PAT) suggests momentum carried into the new year, and the board's decision to pay a special dividend signals confidence in cash generation.

The investment debate now shifts from balance-sheet survival to earnings quality and durability. Three issues matter most. First, gross margin has slipped every year since FY2024; the company must show that new HD and crop-specific products and the equipment business can arrest this. Second, the working-capital improvement has yet to be tested by a weak monsoon year; a reversal would quickly erode the re-rating. Third, disclosure is thin — no earnings calls, no product or regional splits, no R&D data — which constrains institutional ownership (mutual funds hold nothing) and keeps the stock illiquid.

At ~14.6x trailing earnings and ~7x EV/EBITDA, after a ~35% post-results rally, the valuation is no longer distressed but is undemanding for a near-debt-free, mid-teens-ROE specialty agri-input pure play if growth holds at mid-teens rates. The balance of evidence supports a constructive but monitored stance: the turnaround is substantiated by filings, but investors should require continued receivable discipline and gross-margin stabilisation through FY2027 before underwriting a further re-rating, and should treat any adverse monsoon as the principal downside trigger.


Principal sources: NSE/BSE Regulation 30 filings and iXBRL integrated financial results (13 Nov 2025; 28 May 2026; 11 Aug 2026); Aries Agro press releases (29 May 2026; 12 Aug 2026); Reg. 30 disclosures on Sayakha (12 Feb 2026) and Unnao (5 Mar 2026) units; FY2025 Board's Report and MD&A (via IIFL); AGM 2022 chairman's speech; CRISIL rating rationales (Aug 2017, Jan 2022, Mar 2023, May 2024); CARE releases (2018, 2019, Dec 2020); Brickwork rationale (Feb 2021); StockAnalysis, TipRanks, Screener, Tapetide, Anand Rathi, IIFL, Upstox, MarketsMojo, Emkay, BFSL, ScanX, PTI/HDFC Sky, Business News This Week, The Machine Maker, Global Agriculture (Oct 2026), Mordor Intelligence (via GII/DRI), IMARC Group, HTF MI, DivvyDiary, Zonebourse, Univest.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure / notesCompensation (latest)

Dr. Rahul Mirchandani

Chairman & Managing Director; largest promoter shareholder (28.67%)

Long-serving CMD (exact start n.v.); re-appointed MD for 5 years from 1 Apr 2027 (board 11 Aug 2026; AGM 29 Sep 2026). Recipient of a "CEO of the Year" award (date n.v.)

—

Chhaya Ashok Warrier

CFO & Senior Vice President

n.v.

n.v.

Qaiser P. Ansari

Company Secretary & Compliance Officer

Signatory on filings since at least 2018

n.v.

Board of Directors

DirectorCategoryNotes

Dr. Rahul Mirchandani

Chairman & MD (Executive, Promoter)

Combined Chair/CEO role

Mrs. Nitya Mirchandani

Non-Executive, Non-Independent (Promoter group, 0.02%)

Director since at least 2018

Ramamurthy Sundaresan

Non-Executive, Non-Independent

Background n.v.

Nrupang B. Dholakia

Independent Director

—

R. V. Balasubramaniam Iyer

Independent Director

—

Dr. Shailesh Ramesh Karnik

Independent Director

Appointed Additional Director (Independent) 13 Aug 2024

Board & Management Changes

DateChange

13 Aug 2024

Dr. Shailesh Ramesh Karnik appointed Independent Director

26 Sep 2024

Cessation of an independent director (name n.v.)

Jan 2025

Demise of Dr. Jimmy Mirchandani (Non-Executive Non-Independent Director)

11 Aug 2026

Board approved re-appointment of Dr. Rahul Mirchandani as MD for 5 years from 1 Apr 2027; AGM agenda also included re-appointment of an independent director

Governance Detail

CategorySep 2025Dec 2025Mar 2026Jun 2026

Promoters and promoter group (%)

52.6652.6652.6652.66

Foreign institutional investors (%)

3.202.913.253.13

Domestic institutions (%)

0.000.000.000.02

Retail and others (%)

44.1444.4344.0944.19

Major Shareholders

HolderShares%

Rahul Mirchandani

3,728,27528.67

Jimmy Mirchandani (estate)

2,624,83020.18

Akshay J. Mirchandani

421,1753.24

Amol Mirchandani

70,6460.54

Nitya Mirchandani

3,0000.02

Total promoter group

6,847,92652.66

Competitive Landscape

Key Competitors

CompetitorTypeOverlap with AriesRelative positioning

Coromandel International Ltd

Diversified fertiliser and crop-protection major (Murugappa)

Micronutrients, secondary nutrients, water-soluble and specialty nutrients

Far larger scale and distribution; strong in South India

Chambal Fertilisers & Chemicals Ltd

Urea/phosphate major

Micronutrients and specialty nutrients (traded)

Scale; listed by Mordor among top players

Deepak Fertilisers & Petrochemicals Corp. Ltd

Fertiliser and chemicals (Mahadhan brand)

Specialty and water-soluble fertilisers

Strong in Maharashtra horticulture — direct overlap with Aries' core markets

Indian Farmers Fertiliser Cooperative (IFFCO)

Cooperative

Micronutrients, water-soluble, nano-fertilisers

Cooperative reach; price competition

Yara India (Yara International)

Multinational

Specialty and water-soluble nutrition, micronutrients

Premium global brand

Mangalore Chemicals & Fertilizers Ltd

Fertiliser (Adventz group)

Micronutrients/specialty

Regional (Karnataka)

UPL Ltd

Agrochemicals major

Micronutrients/biostimulants

Agri-input bundle; global

Gujarat State Fertilizers & Chemicals Ltd

State fertiliser company

Specialty and water-soluble fertilisers

Gujarat stronghold

Fertilizers & Chemicals Travancore Ltd

PSU fertiliser

Secondary/specialty nutrients

Kerala/South

Madhya Bharat Agro Products Ltd

Small listed phosphate/sulphur fertiliser player

Sulphur and secondary nutrients

Closest listed small-cap peer by scale

Grupa Azoty S.A. (Poland)

Multinational

Imported micronutrients

Cited by Mordor among top players

Unorganised regional formulators

Local

Non-chelated sulphate micronutrients

Price-led; quality inconsistency

Peer Comparison FY2025

MetricAries AgroCoromandel InternationalChambal FertilisersDeepak Fertilisers

Revenue (INR Cr)

622 (FY2025); 740 (FY2026)

~24,000 (approx., n.v. this session)

~16,600 (approx., n.v.)

~10,300 (approx., n.v.)

Revenue growth FY2025 (%)

20.5

n.v.

n.v.

n.v.

EBITDA margin (%)

11.6 (net-revenue basis)

n.v.

n.v.

n.v.

Net margin (%)

5.4

n.v.

n.v.

n.v.

R&D intensity (%)

—

n.v.

n.v.

n.v.

Business focus

Pure-play specialty micronutrients

Diversified

Primary nutrients dominant

Chemicals + fertilisers

Recent Developments

Litigation, regulatory actions, layoffs or guidance revisions: none identified in the period.

Company Snapshot

$85.5M

Revenue

1969

Founded

Mumbai, India

Headquarters

SWOT Analysis

Strengths

  • Category leadership in organised chelates — CRISIL (Jan 2022) estimated ~30% share of the organised domestic chelated micronutrient market.
  • Accelerating growth — consolidated net revenue +20.5% (FY2025) and +18.9% (FY2026); Q1 FY2027 +16.3%.
  • Near-zero leverage — net debt cut from INR 112 cr (FY2022) to INR 7 cr (FY2026); net debt/EBITDA 0.08x.
  • Improving working capital — receivable days 53 → 35 and WC cycle 89 → 64 days in FY2026 (company press release).
  • Consistent cash generation — positive FCF every year FY2022–FY2026, averaging ~INR 52 cr.
  • Demand visibility — annual dealer bookings of ~INR 830 cr (FY2026) from 1,717 dealers in 26 states.
  • Manufacturing reach — 101,400 MT p.a. capacity across multiple states plus UAE production, with ~28% headroom.

Weaknesses

  • Thin net margins — net margin only 5.7% (FY2026) despite ~40% gross margin, due to high selling costs and discounts (~23% of gross revenue).
  • Gross-margin erosion — 43.0% (FY2024) → 40.4% (FY2026).
  • Extreme seasonality — Q4 FY2026 consolidated loss of INR 4.8 cr; Q4 FY2026 standalone loss INR 3.5 cr.
  • Small scale — FY2026 revenue ~INR 740 cr vs majors at INR 10,000–24,000 cr.
  • Weak disclosure — no product, geography or R&D spend disclosure; no investor presentations or earnings calls identified.
  • Governance concentration — combined Chair & MD; promoter 52.66%; 50% board independence (minimum).
  • Utilisation — capacity utilisation 71.8% (Mar 2026) dilutes return on the expanded asset base.

Opportunities

  • Market growth — India micronutrient market forecast ~6.7% CAGR to 2030 (Mordor).
  • Chelated penetration — non-chelated still ~63% of market (IMARC), offering mix-upgrade runway.
  • High-value horticulture — Grapemin, mango/potato grower partnerships, HD liquids for fertigation.
  • Equipment/IPM adjacency — Aries Agro Equipments revenue +92% in FY2026.
  • UAE platform — Fujairah sulphur pastilles and Amarak's new operations could support exports and backward integration.
  • Capital-return capacity — FY2026 special dividend signals scope for higher payouts from FCF.
  • Institutional discovery — mutual-fund holding is nil; any MF entry could broaden the shareholder base.

Threats

  • Monsoon risk — management itself flags weather and cropping patterns as key drivers.
  • Input-cost / FX volatility — reliance on imported raw materials; FY2025 MD&A cites price volatility.
  • Competition from majors — Coromandel, Deepak, IFFCO, Yara expanding specialty/water-soluble lines.
  • Dealer credit risk — B2B dealer model historically produced 400–600-day cash-conversion cycles (Tapetide, FY2015–FY2020).
  • Regulatory risk — Fertiliser Control Order grade changes, quality enforcement, customs-duty changes (CRISIL 2022 noted a duty increase on imported finished product).
  • Subsidiary losses — UAE entities generated non-controlling-interest losses (INR 0.48 cr NCI loss FY2026); long-term investments of ~INR 65 cr carry impairment risk.
  • Promoter succession / estate transfer — ~20% stake still in the late director's name (Jun 2026).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
22 May 2025FY2025 audited results; consolidated net revenue INR 622.2 cr (+20.5%), PAT INR 33.5 cr (+82%); dividend INR 1.20 recommendedEarnings inflection confirmed
Aug 2025Credit rating reaffirmed (per Board's Report)Stable credit standing
Aug 2025FY2026 annual dealer booking INR 830.44 cr (1,717 dealers, 26 states) disclosedDemand visibility
13 Aug 2025Q1 FY2026 results (PAT INR 9.93 cr); AGM and record date fixedSeasonal low quarter
5 Aug 2025Aggregator flagged a "new risk" item (nature n.v.)Low
19 Sep 2025Record/ex-date for FY2025 dividendRoutine
26 Sep 20252025 AGMRoutine governance
17 Oct 2025FY2025 dividend paidRoutine
4 Nov 2025Board meeting intimation; trading window closed 1 Oct–15 Nov 2025Routine
13 Nov 2025Q2 FY2026 results: PBT INR 28.05 cr, PAT INR 19.92 cr (consolidated PAT +6% YoY)Strongest quarter of FY2026
Nov–Dec 2025Monthly SEBI special-window share-transfer reportsCompliance
19 Dec 2025Rahul Mirchandani acquires 180,000 shares via transmission; stake 28.67%Succession of late director's estate
12 Feb 2026Sayakha (Bharuch) plant inaugurated; capacity 101,400 MT p.a.Capacity +6.3%
13 Feb 2026Q3 FY2026 results: net sales INR 200.9 cr (+19.6%), PAT INR 17.3 cr (+50.8%)Strong rabi season
26 Feb 2026Associate Amarak Chemicals FZC reported to commence operations at a facilityUAE associate turnaround potential
5 Mar 2026Relocated Unnao (UP) plant inaugurated; INR 12 cr, internal accruals; utilisation 71.8%Owned premises; no capacity change
30 Mar 2026Sourav Ganguly appointed brand ambassador (3 years)Brand spend step-up
1 Apr 2026Trading window closed until 30 May 2026Routine
21 May 2026Board meeting intimation for FY2026 results and dividendRoutine
28 May 2026FY2026 audited results: net revenue INR 740.1 cr (+18.9%), PAT INR 42.4 cr (+26.5%), EPS INR 32.95; Q4 loss INR 4.8 cr; special dividend INR 1Record year; higher payout
29 May 2026Press release: gross revenue INR 956.9 cr; EBITDA INR 88.9 cr; WC cycle 64 daysWorking-capital story
Jun 2026Shareholding: FII 3.13%; first DII holding (0.02%)Marginal institutional interest
1 Jul 2026Trading window closed for Q1 FY2027Routine
11 Aug 2026Q1 FY2027 results: net revenue INR 185.9 cr (+16.3%), PAT INR 14.9 cr (+49%); MD re-appointment approved; AGM 29 Sep 2026; record date 22 Sep 2026Strong start to FY2027
12 Aug 2026Q1 press release; management reiterates seasonality/weather sensitivityContext
Late Aug 2026Shares trade ~INR 480–502; 52-week high ~INR 525Re-rating
22 Sep 2026Record date for FY2026 dividends (final + special)Shareholder return
29 Sep 20262026 AGM held; chairman's speech filedGovernance
1 Oct 2026Company-sourced media: capacity 101,400 MT, 30 depots, new products, 3,958 farmer meetingsOperating update
By 23 Oct 2026 (scheduled)FY2026 dividend paymentPending
Expected mid-Nov 2026Q2 FY2027 results (date not yet verified)Key catalyst

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

2 charts
Revenue by Segment: Micronutrient Fertilizers revenue rose from INR 5,164.6 Mn in FY2024 to INR 7,400.6 Mn in FY2026.
Aries Agro Limited — Revenue by Segment
Series (INR Mn)FY2024FY2025FY2026
Micronutrient Fertilizers revenue5,164.66,222.27,400.6
Micronutrient Fertilizers PBT283.8443.9602.9
Gross revenue from operations6,728.68,045.99,568.8
Discounts and rebates1,5641,821.82,168.2
Net revenue from operations5,164.66,222.27,400.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.